A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials


Burton B. K., Skalicky A., Baerwald C., Bilder D. A., Harding C. O., Ilan A. B., ...Daha Fazla

MOLECULAR GENETICS AND METABOLISM REPORTS, cilt.29, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.ymgmr.2021.100810
  • Dergi Adı: MOLECULAR GENETICS AND METABOLISM REPORTS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: Phenylketonuria, PKU, Clinical outcome assessments, Adults, Patient-reported outcomes, Observer-reported outcomes, Clinician-reported outcomes, QUALITY-OF-LIFE, PRO INSTRUMENTS, PKU, DISORDERS, ADHERENCE, SYMPTOMS, ISSUES
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction: Current clinical outcome assessments (COAs) are not effectively capturing the complex array of symptoms of adults with phenylketonuria (PKU). This study aimed to identify concepts of interest relevant to adults with PKU. Based on these concepts, COAs for patient-reported outcomes (PROs), observer-reported out-comes (ObsROs), and clinician-reported outcomes (ClinROs) were selected or developed and content validity was assessed.